Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
What is the Cook Celect?
Cook Medical manufactures the Celect Vena Cava Filter. It was approved in 2008 under the FDA 510(k) approval process. This process is a short cut to getting approval for medical devices.
A federal jury in West Virginia today hammered Johnson and Johnson’s Ethicon subsidiary over its transvaginal mesh device. The jury awarded $3.27 million to Jo Huskey over its defective Gynecare TVT Obturator, or TVT-O, transvaginal mesh device. This is one of 33,000 product liability injury lawsuits that claim Johnson & Johnson’s Ethicon Inc unit sold defective transvaginal mesh devices.
Federal Jury Verdict
After a two-week trial, jurors found Ethicon liable for selling defective mesh devices and failing to warn patients and their doctors that they were at risk from serious side effects including pain, erosion, perforation and infection.
According to a Massachusetts jury, Boston Scientific’s vaginal-mesh sling was not defectively designed and the company properly warned about its health risks. This verdict marks a second victory for the company in two state trials over the vaginal mesh inserts.
Jurors in state court in Woburn, Massachusetts, cleared Boston Scientific of any liability for Maria Cardenas’s injuries. Cardenas, had the Boston Scientific’s Obtryx sling implanted to fix urinary incontinence problems. According to Cardenas, the sling caused her pain and she was forced to have it removed surgically.
Transvaginal Mesh and Sling Defects
Common problem with Anticoagulants
Unfortunately, like all anticoagulants, Xarelto has an internal bleeding risk for which there is currently no effective antidote. Thousands of adverse event reports regarding bleeding side effects, including reports of deadly complications, have been filed with the FDA over this blockbuster medication.
A Texas woman is the latest to sue Bayer and Johnson & Johnson pharmaceutical companies, claiming that the anticoagulant Xarelto has inadequate warnings about the bleeding risk associated with the drug. Jeanne Jeffcoat filed the lawsuit in the U.S. District Court for the Eastern District of New York, she claimed that Xarelto caused life-threatening bleeding event that left her permanently injured.
There are many defective drug product liability lawsuits filed nationwide over bleeding and hemorrhage side effects of Xarelto.
Xarelto Aggressive Marketing
There are several thousand lawsuits filed by folks both in state and federal courts by patients who took the prescription drug pioglitazone, sold as brand name Actos and later developed bladder cancer. Doctors prescribe Actos to treat patients with Type 2 Diabetes.
Takeda Actos Bladder Cancer Verdict
On April 7, 2014, a federal jury in Louisiana found Takeda failed to adequately warn about bladder cancer risks of Actos. Jurors also found that executives of Takeda acted with wanton and reckless disregard for patient safety and awarded a total of $9 billion in punitive damages.
For those patients who have been implanted with either a Stryker Rejuvenate or ABG II artificial hipmetal implant, I have an important update to share regarding the status of the defective hip product liability lawsuits and the Stryker hip litigation in general.
What is Stryker Rejuvenate Hip?
The Stryker Rejuvenate is a modular metal based hip replacement, and was recalled from the market in July 2012, after the company indicated that it is subject to fretting, corroding and finally failing shortly after it is implanted.
There has been some success in the lawsuits involving thousands of defective metal on metal hips. Some of the lawsuits have been settled and thousands more are still pending against the metal hip manufacturers including Zimmer (now the new proud owner of Biomet), DePuy, Stryker, Wright Medical and Smith and Nephew that sold the metal-on-metal hip implants.
The defective hip replacement lawsuits share similar allegations that there is premature hip implant failure caused by metal cobalt and chromium release. The artificial hips are made of cobalt chromium alloy and the grinding action of the hip joint in daily activity causing the metal components to rub together, leading to the release of these toxic heavy metal particles.
The release of these metal ions , causing metallosis, damaging tissues in the hip area and causes elevated blood levels of these toxins.
A Massachusetts state jury found for the defense, in the first of more than 20,000 transvaginal mesh lawsuits filed against Boston Scientific. The plaintiff, Diane Albright, claimed that Boston Scientific Pinnacle transvaginal mesh was defective and caused her to suffer significant and painful pelvic injuries.
The Massachusetts jury found that Albright failed to prove her claim that the Boston Scientific mesh was defective or that inadequate warnings were provided about the risk of complications.
This case was the first Boston Scientific mesh lawsuit to go before a jury, and several Boston Scientific mesh trials are expected later next year. In Massachusetts state court, there are 1,700 cases against Boston Scientific, and the next trial is expected to begin on August 11.
A Vermont man who suffered deadly brain bleed has filed a wrongful death lawsuit. The family alleges that the death was caused by side effects of Xarelto, a new generation anticoagulant. Xarelto, has recently come under fire from its irreversible bleeding side effects and is the subject of many similar lawsuits.
Thomas C. Dunkley’s daughter Ruth McGowen, filed a claim against Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary on July 25, in the U.S. District Court for the District of Vermont.
According to the Xarelto allegations, Dunkley was prescribed the blood thinner anticoagulant in July 2012, for treatment of atrial fibrillation to reduce the risk of a embolic stroke.
Dallas Fort Worth Injury Lawyer Blog